News

Fierce Biotech3d
Rhythm’s phase 2 obesity pill trial hits primary endpoint, sending stock up
Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...